Skip to content

Imaging and Evolution of Pigmented Tumors of the Anterior Ocular System in Children

Imaging and Evolution of Pigmented Tumors of the Anterior Ocular System in Children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07120178
Enrollment
53
Registered
2025-08-13
Start date
2025-04-01
Completion date
2025-12-31
Last updated
2025-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pigmented Tumours of the Anterior Ocular System in Children

Keywords

pigmented tumours of the anterior ocular system in children, CONJUNCTIVAL TUMORS CHILDREN

Brief summary

The investigators were interested in pigmented tumours of the anterior segment of the eye in children because there is very little data on their evolution. The nevus is the most common conjunctival tumour. The challenge is to be able to adapt the child's follow-up according to the imaging and avoid an invasive procedure such as surgical excision if the imaging does not find any suspicious cells despite a change in size or colour. This would also make it possible to answer parents' questions about the potential evolution of the tumour. Finally, it would enable the frequency of monitoring to be personalised according to the data analysed. The tests are all non-invasive and painless.

Interventions

data collected: tumor size, pigmentation, vascularization, cells

OTHERdermatoscopy examination x20 and x400

data collected: tumor size, pigmentation, vascularization, cells

OTHERconfocal microscopy examination

data collected: tumor size, pigmentation, vascularization, cells

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patient who had a first dermato-ophthalmological consultation \< 18 years old with pigmented tumors of the anterior ocular system

Exclusion criteria

* patient over 18 years old at first examination

Design outcomes

Primary

MeasureTime frameDescription
The size and pigmentation of the tumorDay 1Measurement of the size of the tumor with dermatoscopy x20 in mm and pigmentation with the slit lamp as well as dermatoscopy x20 and x400

Secondary

MeasureTime frameDescription
Describe the evolution according to ageDay 1Data collected from medical records
Describe the evolution according to sexDay 1Data collected from medical records

Countries

France

Contacts

Primary ContactJean Luc PERROT, Md, PhD
j.luc.perrot@chu-st-etienne.fr(0)477828508

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026